BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 10464838)

  • 21. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
    Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
    Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study on the clinical significance of plasma adrenomedullin and brain natriuretic polypeptide in the patients with chronic cor pulmonale on highland].
    Yang SY; Feng EZ; Shen JL; Xu J; Zhao LH; Wu XM
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Jun; 17(6):361-3. PubMed ID: 15970104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of left ventricular diastolic function on natriuretic peptide levels after cardioversion of atrial fibrillation.
    Bakowski D; Wozakowska-Kapłon B; Opolski G
    Kardiol Pol; 2009 Apr; 67(4):361-7. PubMed ID: 19492248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea.
    Morrison LK; Harrison A; Krishnaswamy P; Kazanegra R; Clopton P; Maisel A
    J Am Coll Cardiol; 2002 Jan; 39(2):202-9. PubMed ID: 11788208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers.
    Gwechenberger M; Huelsmann M; Graf S; Berger R; Bonderman D; Stanek B; Rauscha F; Pacher R
    Eur J Clin Invest; 2004 Dec; 34(12):811-7. PubMed ID: 15606723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of Doppler transmittal flow patterns and cardiac natriuretic peptides in patients with chronic congestive heart failure admitted for episodes of acute decompensation.
    Akioka K; Takeuchi K; Yanagi S; Hirota K; Sakamoto K; Yoshimura T; Toda I; Yoshikawa J
    Heart Vessels; 2000; 15(2):53-60. PubMed ID: 11199504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in chronic renal failure.
    Pedersen EB; Bacevicius E; Bech JN; Solling K; Pedersen HB
    Clin Sci (Lond); 2006 Apr; 110(4):491-501. PubMed ID: 16396628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure.
    Haug C; Metzele A; Steffgen J; Grünert A
    Horm Metab Res; 1994 May; 26(5):246-9. PubMed ID: 8076909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.
    Loke I; Squire IB; Davies JE; Ng LL
    Eur J Heart Fail; 2003 Oct; 5(5):599-606. PubMed ID: 14607197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect.
    Nagaya N; Nishikimi T; Uematsu M; Kyotani S; Satoh T; Nakanishi N; Matsuo H; Kangawa K
    Am Heart J; 1998 Aug; 136(2):297-301. PubMed ID: 9704693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
    Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma atrial and brain natriuretic peptide levels in dogs with congestive heart failure.
    Asano K; Masuda K; Okumura M; Kadosawa T; Fujinaga T
    J Vet Med Sci; 1999 May; 61(5):523-9. PubMed ID: 10379945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma atrial natriuretic Peptide and brain natriuretic Peptide levels after radiofrequency catheter ablation of atrial fibrillation.
    Yamada T; Murakami Y; Okada T; Okamoto M; Shimizu T; Toyama J; Yoshida Y; Tsuboi N; Ito T; Muto M; Kondo T; Inden Y; Hirai M; Murohara T
    Am J Cardiol; 2006 Jun; 97(12):1741-4. PubMed ID: 16765125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
    Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma concentrations of atrial, brain, and C-type natriuretic peptides and endothelin-1 in patients with chronic respiratory diseases.
    Ando T; Ogawa K; Yamaki K; Hara M; Takagi K
    Chest; 1996 Aug; 110(2):462-8. PubMed ID: 8697852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preexisting cardiopulmonary disease attenuating the atrial natriuretic peptide response. Results in patients with acute respiratory failure.
    Westendorp RG; Roos AN; Walma ST; Frölich M; Meinders AE
    Chest; 1992 Dec; 102(6):1758-63. PubMed ID: 1332838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema.
    Karmpaliotis D; Kirtane AJ; Ruisi CP; Polonsky T; Malhotra A; Talmor D; Kosmidou I; Jarolim P; de Lemos JA; Sabatine MS; Gibson CM; Morrow D
    Chest; 2007 Apr; 131(4):964-71. PubMed ID: 17426196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Levels of atrial natriuretic peptide in stable and exacerbated chronic obstructive pulmonary disease].
    Skwarski K; Lee M; MacNee W
    Pneumonol Alergol Pol; 1996; 64(9-10):627-37. PubMed ID: 8991558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial natriuretic peptide in stable and decompensated chronic obstructive pulmonary disease.
    Skwarski K; Lee M; Turnbull L; MacNee W
    Thorax; 1993 Jul; 48(7):730-5. PubMed ID: 8153922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.